Improving Diet Protein Intake in Middle-aged Women
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Boca Raton, Florida, United States, 33431
- Florida Atlantic University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- able to understand and respond to questions or instructions in English
- working telephone
- willingness to consume protein-containing animal products,
- willingness to make changes to the diet
Exclusion Criteria:
- self-reported information that they have been told by a medical doctor that they have kidney (renal) disease
- current or past history of a diagnosed eating disorder
- have an internal cardiac pacemaker/defibrillator or other metal-type implant present
- vegan dietary practices
- refusal to make changes to usual dietary protein intake
- usual dietary protein intake greater than 1.2 g per kg body weight
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Coached
10 weeks of diet coaching
|
10-weeks of diet coaching weekly by telephone to improve dietary protein intake
|
|
No Intervention: Not-coached
No coaching provided
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in dietary protein intake from baseline
Time Frame: 12 weeks
|
Assessed changes in dietary protein intake from three 24-hour dietary recalls collected at baseline.
|
12 weeks
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes in muscle mass
Time Frame: 12 weeks
|
Changes in muscle mass from baseline were measured using bioelectrical impedance analysis
|
12 weeks
|
|
Changes in upper body muscle strength
Time Frame: 12 weeks
|
Changes in handgrip strength from baseline were measured using hand dynamometer
|
12 weeks
|
|
Changes in lower body muscle strength and function
Time Frame: 12 weeks
|
Changes in 5-chair stand times from baseline were assessed
|
12 weeks
|
|
Changes in muscle function
Time Frame: 12 weeks
|
Changes in 4 meter gait speed from baseline were assessed
|
12 weeks
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Sareen S Gropper, PhD, Professor, College of Nursing, Florida Atlantic University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
Other Study ID Numbers
- 1440147-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.